Sulaiman Abdur-Rahman is a Litigation Reporter at ALM covering antitrust complaints, federal judicial nominations and legal matters in the Washington, D.C., metro area. He’s an alumnus of Temple University and longtime journalist who previously worked for publications in Pennsylvania and New Jersey. He also performed writing gigs at Babson College and SoFi Technologies Inc. before joining ALM in 2024.
December 02, 2024 | National Law Journal
11 Red State AGs Demand Damages in Antitrust Lawsuit Shaming ESG Climate Investors"BlackRock, Vanguard and State Street formed a cartel to rig the coal market, artificially reduce the energy supply and raise prices," Texas Attorney General Ken Paxton alleged. "Their conspiracy has harmed American energy production and hurt consumers."
By Sulaiman Abdur-Rahman
3 minute read
November 27, 2024 | National Law Journal
'New Circumstances': Winston & Strawn Seek Expedited Relief in NASCAR Antitrust Lawsuit"The need for an immediate preliminary injunction is crystal clear," Winston & Strawn wrote in a renewed motion for extraordinary relief in the NASCAR antitrust lawsuit, citing 11th-hour developments largely redacted in the public filing.
By Sulaiman Abdur-Rahman
3 minute read
November 26, 2024 | National Law Journal
'Water Cooler Discussions': US Judge Questions DOJ Request in Google Search CaseThe Justice Department demanded Google's internal communications in the search engine case in the and delivered closing arguments in the company's advertising tech trial in Virginia.
By Sulaiman Abdur-Rahman
3 minute read
November 25, 2024 | National Law Journal
'Professional Misconduct': Maryland Supreme Court Disbars 86-Year-Old Attorney"We have considered that Respondent practiced law for 60 years without receiving any prior discipline," Justice Jonathan Biran wrote for a unanimous court in disbarring Francis Edward Yeatman. "It is unfortunate that Respondent ended his career as he did. However, the aggravating factors significantly outweigh the mitigating factors in this case."
By Sulaiman Abdur-Rahman
4 minute read
November 22, 2024 | The Legal Intelligencer
Pa. Judicial Nominee Advances While Trump Demands GOP Unity Against Biden PicksThe Senate Judiciary Committee on Thursday voted 11-10 along party lines to advance five of President Joe Biden’s judicial picks for final consideration in the 100-member U.S. Senate.
By Sulaiman Abdur-Rahman
4 minute read
November 21, 2024 | National Law Journal
'Radical Left Judges'?: Trump Demands GOP Unity Against Biden's Judicial PicksThe Senate Judiciary Committee on Thursday voted 11-10 along party lines to advance five of President Joe Biden’s judicial picks for final consideration in the 100-member U.S. Senate.
By Sulaiman Abdur-Rahman
4 minute read
November 21, 2024 | National Law Journal
Read the Document: 'Google Must Divest Chrome,' DOJ Says, Proposing Remedies in Search Monopoly Case"Google must promptly and fully divest Chrome" by selling the browser to a buyer approved by the Justice Department and state attorneys general, U.S. attorneys wrote in a proposed final judgment filed in District of Columbia federal court. "Google may elect to fully divest Android."
By Sulaiman Abdur-Rahman
3 minute read
November 19, 2024 | International Edition
US Lawsuit Seeks Damages from Iran for Role in Oct. 7 Attack on IsraelThe United States has designated Iran a “state sponsor of terrorism” since January 1984, exposing Iran to potential liability under the state sponsor of terrorism exception to the Foreign Sovereign Immunities Act.
By Sulaiman Abdur-Rahman
3 minute read
November 19, 2024 | National Law Journal
Attorneys Go to DC Federal Court Seeking Damages for Plaintiffs in Oct. 7, 2023, Attack on IsraelThe United States has designated Iran a “state sponsor of terrorism” since January 1984, exposing Iran to potential liability under the state sponsor of terrorism exception to the Foreign Sovereign Immunities Act.
By Sulaiman Abdur-Rahman
3 minute read
November 18, 2024 | National Law Journal
'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing DisputeThe Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash replenishment model,” counsel for Eli Lilly—the manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes—alleged in their complaint.
By Sulaiman Abdur-Rahman
3 minute read
Trending Stories